Literature DB >> 19446348

Functional imaging of the human dopaminergic midbrain.

Emrah Düzel1, Nico Bunzeck, Marc Guitart-Masip, Bianca Wittmann, Bjoern H Schott, Philippe N Tobler.   

Abstract

Invasive recording of dopamine neurons in the substantia nigra and ventral tegmental area (SN/VTA) of behaving animals suggests a role for these neurons in reward learning and novelty processing. In humans, functional magnetic resonance imaging (fMRI) is currently the only non-invasive event-related method to measure SN/VTA activity, but it is debated to what extent fMRI enables inference about dopaminergic responses within the SN/VTA. We consider the anatomical and functional parcellation of the primate SN/VTA and find that its homogeneity suggests little variation in the regional specificity of fMRI signals for reward-related dopaminergic responses. Hence, these responses seem to be well captured by the compound fMRI signal from the SN/VTA, which seems quantitatively related to dopamine release in positron emission tomography (PET). We outline how systematic investigation of the functional parcellation of the SN/VTA in animals, new developments in fMRI analysis and combined PET-fMRI studies can narrow the gap between fMRI and dopaminergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446348     DOI: 10.1016/j.tins.2009.02.005

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  89 in total

1.  Expectations and violations: delineating the neural network of proactive inhibitory control.

Authors:  Bram B Zandbelt; Mirjam Bloemendaal; Sebastiaan F W Neggers; René S Kahn; Matthijs Vink
Journal:  Hum Brain Mapp       Date:  2012-02-22       Impact factor: 5.038

Review 2.  The role of the basal ganglia in learning and memory: insight from Parkinson's disease.

Authors:  Karin Foerde; Daphna Shohamy
Journal:  Neurobiol Learn Mem       Date:  2011-09-16       Impact factor: 2.877

3.  Neurobehavioral evidence for the "Near-Miss" effect in pathological gamblers.

Authors:  Reza Habib; Mark R Dixon
Journal:  J Exp Anal Behav       Date:  2010-05       Impact factor: 2.468

4.  Post-learning Hippocampal Dynamics Promote Preferential Retention of Rewarding Events.

Authors:  Matthias J Gruber; Maureen Ritchey; Shao-Fang Wang; Manoj K Doss; Charan Ranganath
Journal:  Neuron       Date:  2016-02-11       Impact factor: 17.173

5.  An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning.

Authors:  Meltem Sevgi; Lionel Rigoux; Anne B Kühn; Jan Mauer; Leonhard Schilbach; Martin E Hess; Theo O J Gruendler; Markus Ullsperger; Klaas Enno Stephan; Jens C Brüning; Marc Tittgemeyer
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

6.  Sleep deprivation is associated with attenuated parametric valuation and control signals in the midbrain during value-based decision making.

Authors:  Mareike M Menz; Christian Büchel; Jan Peters
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

7.  Working memory and anticipatory set modulate midbrain and putamen activity.

Authors:  Yen Yu; Thomas H B FitzGerald; Karl J Friston
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167

Review 8.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  The involvement of the dopaminergic midbrain and cortico-striatal-thalamic circuits in the integration of reward prospect and attentional task demands.

Authors:  Ruth M Krebs; Carsten N Boehler; Kenneth C Roberts; Allen W Song; Marty G Woldorff
Journal:  Cereb Cortex       Date:  2011-06-16       Impact factor: 5.357

10.  Task-load-dependent activation of dopaminergic midbrain areas in the absence of reward.

Authors:  Carsten N Boehler; Jens-Max Hopf; Ruth M Krebs; Christian M Stoppel; Mircea A Schoenfeld; Hans-Jochen Heinze; Toemme Noesselt
Journal:  J Neurosci       Date:  2011-03-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.